初次全膝关节置换术治疗原发性和继发性骨坏死:15年可靠结果
回顾性分析295例(266例患者)因骨坏死行初次全膝关节置换术的连续病例,平均随访9年。全队列15年无翻修生存率为92%,原发与继发性骨坏死相似;但继发性骨坏死再手术风险更高,限制性假体和胫骨柄与翻修风险增加相关。
要点
- 全队列15年无翻修生存率92%,原发与继发性骨坏死无差异。
- 限制性假体和胫骨柄使用与任何翻修风险增加独立相关。
- 年龄<65岁和继发性骨坏死与15年再手术风险增加相关。
核心结论
- 全膝关节置换术治疗原发性骨坏死长期耐久可靠,但继发性骨坏死再手术风险更高。
研究设计与样本
- 回顾性纳入2002年1月至2022年7月单中心连续295例(266例患者)因骨坏死行初次全膝关节置换术的病例,平均随访9年(2-20年)。
主要发现
- 全队列15年无任何翻修生存率为92%(95%CI 87-97),原发性与继发性骨坏死分别为92%(95%CI 87-98)和93%(95%CI 87-100),组间无显著差异(p=0.459)。
- 限制性假体(HR 10.8,95%CI 2.7-43.4;p<0.001)和胫骨柄使用(HR 12.0,95%CI 4.1-35.1;p<0.001)与任何翻修风险增加相关。
- 全队列15年无无菌性松动生存率为97%(95%CI 93-100)。
- 年龄<65岁(HR 2.7,95%CI 1.4-5.4;p=0.005)和继发性骨坏死(HR 1.9,95%CI 1.0-3.4;p=0.044)与15年任何再手术风险增加相关。
临床怎么用
- 对原发性骨坏死患者,全膝关节置换术可作为长期耐久可靠的选项。
- 对继发性骨坏死患者,应告知再手术风险较高并加强术后监测。
- 选择限制性假体或胫骨柄时需权衡翻修风险增加。
局限性
- 回顾性单中心设计,可能存在选择偏倚和随访丢失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Total knee arthroplasty (TKA) for end-stage osteonecrosis has historically been associated with concerns regarding aseptic loosening, and long-term data are limited. The purpose of this study was to update and expand our previous series with long-term follow-up, with specific emphasis on implant survivorship, risk factors for failure, complications, and clinical outcomes in a consecutive cohort of TKAs performed for primary and secondary osteonecrosis. METHODS: We retrospectively identified 295 consecutive TKAs in 266 patients for osteonecrosis performed at a single tertiary care academic institution from January 2002 to July 2022. Of these, 207 TKAs (70%) were performed for primary osteonecrosis, and 88 (30%) for secondary osteonecrosis. The predominant cause of secondary osteonecrosis was steroid use (59%; n = 52), followed by post-traumatic (25%; n = 22), radiation-induced (9%; n = 8), and alcohol-induced (7%; n = 6) osteonecrosis. Implant survivorship was analyzed as a time-to-event outcome using Kaplan-Meier estimation. The mean age was 61 years (18 to 93), with 67% being female (n = 197). The mean follow-up was nine years (2 to 20). RESULTS: The 15-year survivorship free of any revision for the entire cohort was 92% (95% CI 87 to 97), with similar rates between primary and secondary osteonecrosis (92% (95% CI 87 to 98) vs 93% (95% CI 87 to 100), respectively; p = 0.459). Varus-valgus constraint implant designs (HR 10.8 (95% CI 2.7 to 43.4); p < 0.001) and tibial stem use (HR 12.0 (95% CI 4.1 to 35.1); p < 0.001) were associated with an increased risk of any revision. The 15-year survivorship free of aseptic loosening was 97% (95% CI 93 to 100) for the entire cohort. Age under 65 years (HR 2.7 (95% CI 1.4 to 5.4); p = 0.005) and secondary osteonecrosis (HR 1.9 (95% CI 1.0 to 3.4); p = 0.044) were associated with an increased risk of any reoperation at 15 years. CONCLUSION: TKA is a durable and reliable option for primary osteonecrosis at long-term follow-up. However, TKAs performed for secondary osteonecrosis carry a higher reoperation risk.
引用
- Meissner N, Weintraub MT, Larson DR, et al. Primary total knee arthroplasty for primary and secondary osteonecrosis : reliable outcomes at 15 years. Bone Joint J. 2026. PMID: 41916586. doi:10.1302/0301-620X.108B4.BJJ-2025-0627.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。